a Shandong Provincial Qianfoshan Hospital, Shandong University , Jinan , China.
b Department of Cardiography , Yantai Affiliated Hospital of Binzhou Medical University , Yantai , China.
Ren Fail. 2018 Nov;40(1):458-465. doi: 10.1080/0886022X.2018.1487868.
Low-intensity pulsed ultrasound (LIPUS) and SonoVue have been used widely for diagnosis and therapeutic treatment. The effects of LIPUS and SonoVue on the microvascular system and underlying molecular mechanisms have not been established.
Cultured human renal glomerular endothelial cells (HRGECs) were treated with 5-min ultrasonic irradiation, 20% SonoVue or the combination of both treatments. Cell proliferation, viablity, and apoptosis were measured by MTT assay, Trypan blue exclusion assay and flow cytometry, respectively. Activation of extracellular regulated protein kinases (ERK) were examined by Western blot.
We found that LIPUS and SonoVue alone do not induce cytotoxicity of HRGECs; however, the combination of the two treatments reduces cell proliferation and increases cell death. In addition, the combination of LIPUS and SonoVue suppressed the activation of ERK 1/2 in HRGRCs. With pretreatment of the inhibitor of ERK1/2 signaling, PD98059, LIPUS, and SonoVue does not induce additional cell death and inhibition of proliferation.
LIPUS combined with SonoVue induces cytotoxicity of HRGECs via repression of the ERK1/2 signaling pathway.
低强度脉冲超声(LIPUS)和 SonoVue 已被广泛用于诊断和治疗。LIPUS 和 SonoVue 对微血管系统及其潜在的分子机制的影响尚未确定。
用 5 分钟超声辐照、20% SonoVue 或两者联合处理培养的人肾小球内皮细胞(HRGECs)。通过 MTT 测定、台盼蓝排除试验和流式细胞术分别测量细胞增殖、活力和凋亡。通过 Western blot 检测细胞外调节蛋白激酶(ERK)的激活。
我们发现,LIPUS 和 SonoVue 单独使用不会诱导 HRGECs 的细胞毒性;然而,两种处理的联合减少了细胞增殖并增加了细胞死亡。此外,LIPUS 和 SonoVue 的联合抑制了 HRGRCs 中 ERK1/2 的激活。用 ERK1/2 信号通路的抑制剂 PD98059 预处理后,LIPUS 和 SonoVue 不会诱导额外的细胞死亡和增殖抑制。
LIPUS 联合 SonoVue 通过抑制 ERK1/2 信号通路诱导 HRGECs 的细胞毒性。